PubMed for id: 10253

Year	Number of Results
1998	1
2000	4
2001	3
2002	7
2003	5
2004	9
2005	11
2006	8
2007	11
2008	12
2009	10
2010	22
2011	22
2012	9
2013	14
2014	16
2015	17
2016	14
2017	8
2018	12
2019	6
2020	2
2021	9
2022	3
2023	3
2024	2

1

The Prognostic and Functional Impact of Sprouty 2 Expression in Non-small Cell Lung Cancer.

Acikgoz Y, Yildirim FU, Esen SA, Ucar G, Ergun Y, Bal O, Dogan M, Uncu D. Acikgoz Y, et al. Am J Clin Oncol. 2023 Dec 1;46(12):543-550. doi: 10.1097/COC.0000000000001044. Epub 2023 Sep 13. Am J Clin Oncol. 2023. PMID: 37700432

2

Epigenetic DNA Modifications Upregulate SPRY2 in Human Colorectal Cancers.

Stuckel AJ, Zeng S, Lyu Z, Zhang W, Zhang X, Dougherty U, Mustafi R, Zhang Q, Joshi T, Bissonnette M, Choudhury SR, Khare S. Stuckel AJ, et al. Cells. 2021 Oct 2;10(10):2632. doi: 10.3390/cells10102632. Cells. 2021. PMID: 34685612 Free PMC article.

3

Spatial signal repression as an additional role of Sprouty2 protein variants.

Dittmer J, Stütz A, Vanas V, Salhi J, Reisecker JM, Kral RM, Sutterlüty-Fall H. Dittmer J, et al. Cell Signal. 2019 Oct;62:109332. doi: 10.1016/j.cellsig.2019.05.017. Epub 2019 May 30. Cell Signal. 2019. PMID: 31154002

4

Haplotype and Haplotype-Environment Interaction Analysis Revealed Roles of SPRY2 for NSCL/P among Chinese Populations.

Zhou R, Wang M, Li W, Wang S, Zheng H, Zhou Z, Hu Y, Li J, Wu T, Zhu H, Beaty TH. Zhou R, et al. Int J Environ Res Public Health. 2019 Feb 15;16(4):557. doi: 10.3390/ijerph16040557. Int J Environ Res Public Health. 2019. PMID: 30769929 Free PMC article.

5

Genome-Wide Association Study Links Receptor Tyrosine Kinase Inhibitor Sprouty 2 to Thrombocytopenia after Coronary Artery Bypass Surgery.

Karhausen JA, Qi W, Smeltz AM, Li YJ, Shah SH, Kraus WE, Mathew JP, Podgoreanu MV, Kertai MD; Duke Perioperative Genetics Safety Outcomes (PEGASUS) Investigative Team. Karhausen JA, et al. Thromb Haemost. 2018 Sep;118(9):1572-1585. doi: 10.1055/s-0038-1667199. Epub 2018 Aug 13. Thromb Haemost. 2018. PMID: 30103242 Free PMC article.

6

Sprouty2 enhances the tumorigenic potential of glioblastoma cells.

Park JW, Wollmann G, Urbiola C, Fogli B, Florio T, Geley S, Klimaschewski L. Park JW, et al. Neuro Oncol. 2018 Jul 5;20(8):1044-1054. doi: 10.1093/neuonc/noy028. Neuro Oncol. 2018. PMID: 29635363 Free PMC article.

7

Sprouty2 Suppresses Epithelial-Mesenchymal Transition of Human Lens Epithelial Cells through Blockade of Smad2 and ERK1/2 Pathways.

Tan X, Zhu Y, Chen C, Chen X, Qin Y, Qu B, Luo L, Lin H, Wu M, Chen W, Liu Y. Tan X, et al. PLoS One. 2016 Jul 14;11(7):e0159275. doi: 10.1371/journal.pone.0159275. eCollection 2016. PLoS One. 2016. PMID: 27415760 Free PMC article.

8

Sprouty2 regulates proliferation and survival of multiple myeloma by inhibiting activation of the ERK1/2 pathway in vitro and in vivo.

Yao Y, Luo J, Bian Y, Sun Y, Shi M, Xia D, Niu M, Zhao K, Zeng L, Chen W, Li Z, Xu K. Yao Y, et al. Exp Hematol. 2016 Jun;44(6):474-482.e2. doi: 10.1016/j.exphem.2016.02.009. Epub 2016 Mar 22. Exp Hematol. 2016. PMID: 27016275 Free article.

9

Differential Effects of Variations at Codon 106 on Sprouty2 Functions in Lung Cancer-Derived Cells.

Kral R, Doriguzzi A, Mayer CE, Krenbek D, Setinek U, Sutterlüty-Fall H. Kral R, et al. J Cell Biochem. 2016 Aug;117(8):1822-32. doi: 10.1002/jcb.25482. Epub 2016 Jan 21. J Cell Biochem. 2016. PMID: 26727965

10

Sprouty2 suppresses the inflammatory responses in rheumatoid arthritis fibroblast-like synoviocytes through regulating the Raf/ERK and PTEN/AKT signals.

Zhang W, Du Z, Zhu J, Yu J, Xu Y. Zhang W, et al. Mol Immunol. 2015 Oct;67(2 Pt B):532-9. doi: 10.1016/j.molimm.2015.07.033. Epub 2015 Aug 8. Mol Immunol. 2015. PMID: 26265114

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

212 results

Results by year